Mississippi study finds telehealth coaching can build diabetes confidence

A patient in Mississippi may live more than 30 miles (48 kilometers) from the nearest clinician. In that landscape, telehealth can extend support to people who face limited local access to care—and a study by the University of Mississippi and the Mississippi Diabetes Network found that personalized coaching helped participants feel more confident making daily diabetes decisions.

The researchers followed 27 patients in Diabetes Solutions, a Mississippi-based diabetes self-management education and support program delivered through telehealth. They were not testing whether the program lowered A1C, the blood test used to track average blood sugar, or measuring another clinical outcome. The focus was the patient experience: what brought people in, what kept them engaged and what made them leave.

That experience turned on relationships. Participants valued coaches who listened without judgment and worked with them on habits they could maintain, rather than simply prescribing medication or listing changes to make. Knowing that someone would celebrate progress and help navigate setbacks made patients feel more confident and less alone, according to Caroline Brock, Catherine Moring and Allison Ford-Wade, the study's co-authors and collaborators.

The finding matters because diabetes management is repetitive and personal: patients must interpret blood sugar readings, understand A1C results and judge how medication, exercise and stress affect their days. For people in rural communities facing limited provider access, transportation barriers, food insecurity and an education gap after diagnosis, telehealth offers a way to maintain support without placing a health-care provider in every community.

So what changes, concretely? The study points to a practical role for remote coaching: helping rural patients keep making informed choices between clinical visits and giving them a trusted person to contact when a plan falters. It does not yet show improved medical measurements, and the evidence comes from interviews with 27 participants, so the program's clinical impact still needs separate evaluation.